MedPath

Fertility Preservation in Case of Endometriosis

Recruiting
Conditions
Endometriosis
Registration Number
NCT03744754
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

Fertility Preservation is now considered as crucial for the well-being of women battling cancer. However, others indications have more recently emerged. Women with endometriosis may represent a suitable group since they are at risk for compromise ovarian reserve. Data on FP in endometriosis patients are rare: only small retrospective study, case-reports and opinion publications .Nowadays, there is no available data concerning real indications for PF on endometriosis patients (endometriomas, risk of surgery, deep endometriosis?), criteria for eligibility (ovarian reserve parameters, age), quality of oocytes and number of oocytes necessary to give at least one live birth.

We propose a monocentric observational cohort study, evaluating the efficacy of oocytes cryopreservation as fertility preservation procedure, in young adult female subjects with endometriosis, to finally define the criteria of eligibility for PF procedures in case of endometriosis.

Detailed Description

Monocentric observational cohort study, enrolling young patients with endometriosis, without birth project for the moment, and asking for fertility preservation, in order to preserve mature oocytes.

Protocol of this study :

* information and signatures of consent file ;

* ovarian stimulation, oocytes retrieval and mature oocytes cryopreservation (one or more procedures)

* questionnaires every year, describing quality of life in this context of endometriosis and evolution (treatment, surgery, ART, pregnancies)

* data about number and rate of thawed oocytes after preservation, pregnancy rate and live birth rate with these oocytes.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • women from 18 to 36 years old
  • endometriosis disease proved by sonography, MRI and/or surgery
  • Consenting to participate to the study
Exclusion Criteria
  • Any contraindication for ovarian stimulation.
  • Any contraindication for pregnancy .- Impossible Follow-up.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
characteristics of patients who will benefit from preservation fertility in case of endometriosis (age, parameters of ovarian reserve, endometriosis stage and lesions, previous treatment or surgeries, previous fertility treatment)5 years

baseline data

Secondary Outcome Measures
NameTimeMethod
Events between fertility preservation and re-use or end of the study 55 years

Type of medical treatement for endometriosis during the year: class of molecule

rate of patients who will re-use their cryopreserved oocytes5 years

follow up data

oocytes survival rate5 years

follow up data

live birth rate5 years

follow up data

Events between fertility preservation and re-use or end of the study 15 years

Nature of surgical procedures for endometriosis during the year

Quality of life, during and after preservation fertility procedure assessed by SF-36 questionnaire5 years

Patients complete a SF-36 questionnaire

Events between fertility preservation and re-use or end of the study 25 years

Number of surgical procedures for endometriosis during the year

Events between fertility preservation and re-use or end of the study 35 years

Pregnancy during the year (and type of pregnancy: abortion, clinical pregnancy, delivery)

Events between fertility preservation and re-use or end of the study 45 years

Duration of medical treatement for endometriosis during the year: number of months during the year

pregnancy rate5 years

follow up data

birth rate5 years

follow up data

Trial Locations

Locations (1)

Service de Gynécologie Obstétrique et Médecine de la Reproduction Hôpital TENON

🇫🇷

Paris, Ile De France, France

© Copyright 2025. All Rights Reserved by MedPath